U.S. Spatial Genomics and Transcriptomics Market to Grow from USD 0.26 Billion to USD 0.71 Billion by 2035, While Europe ...

PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced the ...

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, ...

MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life sciences, today launched Go Spatial in Europe and welcomed Omics Empower GmbH as a ...

A new study generated one of the most comprehensive spatially resolved transcriptomic maps of cellular communication between ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Megan covers the intersection of science and society. How is biomedical research funded? Who benefits? And how do new technologies reflect and shape our values? You can reach Megan on Signal at ...

10x Genomics is re-rated neutral after a 186% rally, with a $30 price target implying limited near-term upside. TXG's fundamentals improved: Q1 gross margin expanded to 70%, GAAP net loss narrowed by ...

The field of cancer genomics is rapidly evolving, driven by advanced technologies that enable detailed characterization of cancer initiation, progression, ...

High-resolution spatial transcriptomics and imaging-based technologies are now generating large-scale, multi-dimensional datasets that are beginning to reshape how we understand tissue organisation, ...